Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events

被引:43
|
作者
Burn, Edward [1 ]
Nghiem, Son [1 ]
Jan, Stephen [2 ]
Redfern, Julie [2 ]
Rodgers, Anthony [2 ]
Thiagalingam, Aravinda [3 ,4 ]
Graves, Nicholas [1 ]
Chow, Clara K. [2 ,3 ,4 ]
机构
[1] Queensland Univ Technol, Brisbane, Qld, Australia
[2] Univ Sydney, George Inst Global Hlth, Sydney Med Sch, Sydney, NSW, Australia
[3] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia
[4] Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
CORONARY-HEART-DISEASE; RISK-FACTOR; LIFE-STYLE; SMOKING; HEALTH; MODEL; INTERVENTIONS; INDIVIDUALS; UNCERTAINTY; STROKE;
D O I
10.1136/heartjnl-2016-310195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To estimate the cost-effectiveness of Tobacco, Exercise and Diet Messages (TEXT ME), a text message-based intervention that provides advice, motivation, information and support to improve health-related behaviours. Methods A lifetime Markov model was used to estimate major vascular events (myocardial infarctions and strokes) avoided, quality-adjusted life years (QALYs) gained, costs to the health system and the incremental cost per QALY gained. The model was informed by data from a randomised controlled trial of TEXT ME, with evidence from systematic reviews and meta-analyses used to estimate the effects of changes in risk factors on the risk of major vascular events. Expected costs and health outcomes were estimated with uncertainty surrounding these characterised using probabilistic sensitivity analysis and a number of scenario analyses. Results For a target population of 50 000 patients with documented coronary heart disease, the intervention is expected to lead to 563 fewer myocardial infarctions, 361 fewer strokes and 1143 additional QALYs. TEXT ME is expected to lead to an overall saving of $ 10.56 million for the health system over the patients' lifetimes. The intervention can therefore be considered cost-saving and health-improving. Neither parameter nor structural uncertainty had a significant impact on the conclusion that TEXT ME is cost-effective. Conclusions The provision of TEXT ME is predicted to lead to better health outcomes and an overall saving in costs for the health system.
引用
收藏
页码:923 / U57
页数:8
相关论文
共 50 条
  • [31] Cost-Effectiveness of Atorvastatin in the Primary Prevention of Major Cardiovascular Events in Patients with Type 2 Diabetes in Canada
    Khoury, Hanane
    Wagner, Monika
    Merikle, Elizabeth
    Johnson, Scott J.
    Roberts, Craig
    CANADIAN JOURNAL OF DIABETES, 2009, 33 (04) : 363 - 374
  • [32] Role of prevention: cost-effectiveness of prevention
    Berrino, F
    ANNALS OF ONCOLOGY, 2004, 15 : 245 - 248
  • [33] Avahan and the cost-effectiveness of "prevention as prevention"
    Marseille, Elliot
    Kahn, James G.
    LANCET GLOBAL HEALTH, 2014, 2 (09): : E493 - E494
  • [34] Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk
    Greving, Jacoba P.
    Buskens, Erik
    Koffijberg, Hendrik
    Algra, Ale
    CIRCULATION, 2008, 117 (22) : 2875 - 2883
  • [35] The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage
    Ofman, J
    Wallace, J
    Badamgarav, E
    Chiou, CF
    Henning, J
    Laine, L
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (08): : 1941 - 1950
  • [36] COST-EFFECTIVENESS OF DABIGATRAN FOR THROMBOEMBOLIC EVENTS PREVENTION IN ATRIAL FIBRILLATION PATIENTS
    Abbott, T.
    Armijo, N.
    Balmaceda, C.
    Espinoza, M. A.
    VALUE IN HEALTH, 2022, 25 (12) : S152 - S152
  • [37] Cost-effectiveness of a telemonitoring programme in patients with cardiovascular diseases compared with standard of care
    Ziegler, Andreas
    Oner, Alper
    Quadflieg, Gisela
    Betschart, Raphael O.
    Thiery, Alexandre
    Babel, Hugo
    Mwambi, Henry G.
    Neumeyer, Henriette
    Mackschin, Steffen
    Hintz, Sissy
    Mann, Miriam
    Dittrich, Hermann
    Schmidt, Christian
    HEART, 2023, 109 (21) : 1617 - 1623
  • [38] Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
    Fonarow, Gregg C.
    Keech, Anthony C.
    Pedersen, Terje R.
    Giugliano, Robert P.
    Sever, Peter S.
    Lindgren, Peter
    van Hout, Ben
    Villa, Guillermo
    Qian, Yi
    Somaratne, Ransi
    Sabatine, Marc S.
    JAMA CARDIOLOGY, 2017, 2 (10) : 1069 - 1078
  • [39] Influenza vaccination in acute coronary syndromes patients in Thailand: the cost-effectiveness analysis of the prevention for cardiovascular events and pneumonia
    Sribhutorn, Apirak
    Phrommintikul, Arintaya
    Wongcharoen, Wanwarang
    Chaikledkaew, Usa
    Eakanunkul, Suntara
    Sukonthasarn, Apichard
    JOURNAL OF GERIATRIC CARDIOLOGY, 2018, 15 (06) : 413 - 421
  • [40] Influenza vaccination in acute coronary syndromes patients in Thailand:the cost-effectiveness analysis of the prevention for cardiovascular events and pneumonia
    Apirak Sribhutorn
    Arintaya Phrommintikul
    Wanwarang Wongcharoen
    Usa Chaikledkaew
    Suntara Eakanunkul
    Apichard Sukonthasarn
    Journal of Geriatric Cardiology, 2018, 15 (06) : 413 - 421